Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study by Young, GJ, Harrison, S, Turner, EL, Walsh, EI, Oliver, SE, Ben-Shlomo, Y, Evans, S, Lane, JA, Neal, DE, Hamdy, FC, Donovan, JL, Martin, RM, Metcalfe, C

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial by Donovan, JL, Young, GJ, Walsh, EI, Metcalfe, C, Lane, JA, Martin, RM, Tazewell, MK, Davis, M, Peters, TJ, Turner, EL, Mills, N, Khazragui, H, Khera, TK, Neal, DE, Hamdy, FC, ProtecT Study Group

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial by Martin, RM, Donovan, JL, Turner, EL, Metcalfe, C, Young, GJ, Walsh, EI, Lane, JA, Noble, S, Oliver, SE, Evans, S, Sterne, JAC, Holding, P, Ben-Shlomo, Y, Brindle, P, Williams, NJ, Hill, EM, Ng, SY, Toole, J, Tazewell, MK, Hughes, LJ, Davies, CF, Thorn, JC, Down, E, Davey Smith, G, Neal, DE, Hamdy, FC, CAP Trial Group

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer by Hamdy, FC, Donovan, JL, Lane, JA, Metcalfe, C, Davis, M, Turner, EL, Martin, RM, Young, GJ, Walsh, EI, Bryant, RJ, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Rosario, DJ, Rowe, E, Mason, M, Catto, JWF, Peters, TJ, Oxley, J, Williams, NJ, Staffurth, J, Neal, DE

Patient-reported outcomes 12 years after localized prostate cancer treatment by Donovan, JL, Hamdy, FC, Lane, JA, Young, GJ, Metcalfe, C, Walsh, EI, Davis, M, Steuart-Feilding, T, Blazeby, JM, Avery, KNL, Martin, RM, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Rosario, DJ, Rowe, E, Mason, M, Catto, JWF, Peters, TJ, Wade, J, Turner, EL, Williams, NJ, Oxley, J, Staffurth, J, Bryant, RJ, Neal, DE

A genetic hazard score to personalize prostate cancer screening, applied to population data by Huynh-Le, M-P, Fan, CC, Karunamuni, R, Walsh, EI, Turner, EL, Lane, JA, Martin, RM, Neal, DE, Donovan, JL, Hamdy, FC, Parsons, JK, Eeles, RA, Easton, DF, Kote-Jarai, Z, Olama, AAA, Garcia, SB, Muir, K, Gronberg, H, Wiklund, F, Aly, M, Schleutker, J, Sipeky, C, Tammela, TLJ, Nordestgaard, BG, Key, TJ, Travis, RC, Pharoah, P, Pashayan, N, Khaw, K-T, Thibodeau, SN, McDonnell, SK, Schaid, DJ, Maier, C, Vogel, W, Luedeke, M, Herkommer, K, Kibel, AS, Cybulski, C, Wokolorczyk, D, Kluzniak, W, Cannon-Albright, L, Brenner, H, Schöttker, B, Holleczek, B, Park, JY, Sellers, TA, Lin, H-Y, Slavov, C, Kaneva, R, Mitev, V, Batra, J, Clements, JA, Spurdle, A, Teixeira, MR, Paulo, P, Maia, S, Pandha, H, Michael, A, Kierzek, A, Mills, IG, Andreassen, OA, Dale, AM, Seibert, TM